Mitchell P. Kopin 13D and 13G filings for Vivos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-30 5:39 pm Purchase | 2024-12-22 | 13G | Vivos Therapeutics, Inc. VVOS | Mitchell P. Kopin | 297,315 4.990% | 297,315 (New Position) | Filing |